Substance Abuse Policy
Template — South Africa

Declaration of the organisation's commitment to a substance-free workplace, the dual objectives of workplace safety and employee wellbeing, the scope of the policy (all employees, contractors, temporary staff, and visitors on company premises), and the acknowledgement that substance addiction is a treatable medical condition entitled to fair and compassionate management.

Comprehensive prohibition on being under the influence of alcohol, illegal drugs, or misused prescription medication while on duty, on company premises, or while representing the company. Prohibition on the possession, distribution, sale, or manufacturing of prohibited substances in the workplace — conduct that also constitutes criminal offences under the Drug and Drug Trafficking Act 140 of 1992 and may be reported to the SAPS.

Detailed testing procedures covering five types: pre-employment testing (with consent as a condition of employment), random testing (objective selection, applied consistently), reasonable suspicion testing (trained supervisor observations, documented indicators), post-incident testing (after workplace accidents or near-misses), and return-to-duty testing (after rehabilitation). Covers testing methods (breathalyser for alcohol, urine and oral fluid for drugs), chain of custody requirements, confirmatory testing by an accredited laboratory, and the employee's right to request a retest at their own cost.

Identification of roles where impairment poses an elevated risk to the employee, colleagues, and the public — including vehicle operators, forklift drivers, crane operators, workers at heights, machine operators, security personnel, medical staff, and workers handling hazardous materials. Enhanced testing frequency for these roles, zero-tolerance blood alcohol content thresholds (0.00g/100ml for safety-critical roles versus the standard 0.05g/100ml), and the obligation to report to work in a fit and unimpaired state.

Voluntary self-referral pathway for employees who recognise a substance problem before it results in a policy violation. Management referral following a positive test or observed impairment. Strict confidentiality of EAP participation under POPIA. The employer's commitment to support rehabilitation as the first response to addiction (incapacity) rather than immediate dismissal. The scope of rehabilitation support — typically including assessment, inpatient or outpatient treatment, and aftercare — and the employer's financial contribution to treatment costs where applicable.

Clear framework distinguishing between misconduct (being intoxicated at work in violation of the policy, refusing a test, distributing substances) and incapacity (alcohol or drug addiction that impairs the ability to perform). The misconduct route follows the standard disciplinary process under Schedule 8 Items 3-4. The incapacity route follows Items 10-11, requiring the employer to investigate the extent of the incapacity, offer counselling and rehabilitation, monitor progress, and only dismiss after a fair process demonstrates that the employee cannot be accommodated.

Clear provisions establishing that refusal to submit to a lawful substance test requested under the policy constitutes insubordination and may be treated as misconduct warranting disciplinary action. The rebuttable presumption that an employee who refuses testing may be under the influence. The requirement that the test request must be lawful (based on reasonable grounds and conducted with due regard for the employee's dignity) for the refusal to constitute misconduct.

Conditions for returning to work after rehabilitation — medical clearance from a treating practitioner, return-to-duty testing with negative results, ongoing monitoring and follow-up testing for a defined period (typically 12-24 months), modified duties where appropriate, and a relapse management protocol. The relapse protocol distinguishes between a genuine relapse (requiring further treatment support) and a wilful violation (warranting misconduct discipline).

Provisions ensuring that substance testing and the handling of test results comply with constitutional rights (section 10 dignity, section 14 privacy) and POPIA requirements. Private collection of samples, same-gender collectors where applicable, chain of custody documentation, secure storage of test results, access limited to the designated medical officer and authorised HR personnel, retention periods, and the prohibition on disclosing results to persons outside the defined need-to-know group.

Obligations for employees taking prescription medication that may impair their ability to perform work safely — including the duty to disclose to a line manager or the company's occupational health practitioner (without disclosing the specific condition), the assessment of whether the medication affects safety-sensitive duties, and temporary reassignment where impairment risk exists. Provisions protecting the employee's medical privacy while managing safety obligations.

Progressive disciplinary framework aligned with LRA Schedule 8, with specific sanctions for substance-related offences: first offence of intoxication (final written warning with mandatory EAP referral for non-safety-sensitive roles; summary dismissal for safety-sensitive roles), possession of illegal substances (summary dismissal plus SAPS referral), distribution or sale of substances (summary dismissal plus SAPS referral), and repeated violations after rehabilitation (dismissal after due incapacity process).